Sponsor
Orexo AB
Virdings Alle 32 A, Vaksala, 754 50 Uppsala, Sweden
About the sponsor
Research activity centers on anaphylaxis and the rapid treatment of severe allergic reactions, with attention to epinephrine delivery in acute care settings.
- Emergency treatment of anaphylaxis
- Epinephrine-based therapy
- Rapid symptom control in allergic reactions
The sponsor’s clinical interest is directed toward nasal epinephrine as a treatment option relevant to allergic rhinitis and urgent hypersensitivity management.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.